Glimepiride , Pioglitazone Hydrochloride and Metformin Hydrochloride (Sustained Release) Tablets | Brand – Minmek-PG2 | Manufacturer – CARDMEK | Pack of 1×10 Tab

Description:Minmek-PG2 is a comprehensive formulation combining Glimepiride, Pioglitazone Hydrochloride, and Metformin Hydrochloride (Sustained Release) to effectively manage type 2 diabetes. This combination addresses multiple pathways in glucose control, offering a balanced approach to blood sugar regulation.Key Benefits:Glimepiride: Stimulates insulin release from the pancreas, enhancing glucose controlPioglitazone Hydrochloride: Improves insulin sensitivity in muscle and fat tissues, reducing insulin resistanceMetformin Hydrochloride (Sustained Release): Provides extended glucose control by decreasing liver glucose production and improving insulin actionHelps maintain stable blood sugar levels and reduces the risk of diabetes-related complicationsComposition:Glimepiride: Enhances insulin secretion to lower blood glucose levelsPioglitazone Hydrochloride: Increases the body’s sensitivity to insulinMetformin Hydrochloride (Sustained Release): Ensures prolonged and consistent blood glucose regulationRecommended Usage:Take 1 tablet daily with food or as prescribed by your healthcare provider. Dosage may be adjusted based on individual blood glucose levels and therapeutic response.